Protective effectiveness of hantavirus vaccine

231 374

Cited 45 times in

DC Field	Value	Language
dc.date.accessioned	2020-09-04T02:06:51Z	-
dc.date.available	2020-09-04T02:06:51Z	-
dc.date.issued	2004-12	-
dc.identifier.issn	1080-6040	-
dc.identifier.uri	https://ir.ymlib.yonsei.ac.kr/handle/22282913/178815	-
dc.description.abstract	A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.	-
dc.description.statementOfResponsibility	open	-
dc.language	English	-
dc.publisher	National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC)	-
dc.relation.isPartOf	EMERGING INFECTIOUS DISEASES	-
dc.rights	CC BY-NC-ND 2.0 KR	-
dc.title	Protective effectiveness of hantavirus vaccine	-
dc.type	Article	-
dc.contributor.googleauthor	Keeho Park	-
dc.contributor.googleauthor	Chang Soo Kim	-
dc.contributor.googleauthor	Ki-Tae Moon	-
dc.identifier.doi	10.3201/eid1012.040684	-
dc.relation.journalcode	J00767	-
dc.identifier.eissn	1080-6059	-
dc.identifier.pmid	15663866	-
dc.citation.volume	10	-
dc.citation.number	12	-
dc.citation.startPage	2218	-
dc.citation.endPage	2220	-
dc.identifier.bibliographicCitation	EMERGING INFECTIOUS DISEASES, Vol.10(12) : 2218-2220, 2004-12	-

Show simple item record Find it @ YMLIB

YUHSpace: Protective effectiveness of hantavirus vaccine